MIXiii-Biomed Israel 2019 Conference and Exhibition
  • Home
  • Conference
    • Welcome Letter
    • Committees
    • Meet the Speakers of 2019
    • Program
      • Day 1
      • Day 2
      • Day 3
    • Instructions for Oral Presentations
    • Call for Company Presentations
    • Past Events
  • Exhibition
    • Start-up Area – List of Exhibitors
    • How to Exhibit
    • Information for Exhibitors
    • Sponsors & Exhibitors List
    • Digital Catalogue 2019
  • Sponsorship
  • Registration
  • Accommodations
    • Hotel Accommodations
    • Accommodation Reservation
  • Business Forum
    • Networking
  • Social
    • Satellite Events
    • Publications
    • Social Networks & PR Services
    • Media Partners
  • General
    • About Us
    • About Tel-Aviv
    • FAQ
    • Biomed 2018 by the Numbers
    • Gallery
    • Tours for Visitors
    • Privacy Policy
  • Contact
  • Home
  • Conference
    • Welcome Letter
    • Committees
    • Meet the Speakers of 2019
    • Program
      • Day 1
      • Day 2
      • Day 3
    • Instructions for Oral Presentations
    • Call for Company Presentations
    • Past Events
  • Exhibition
    • Start-up Area – List of Exhibitors
    • How to Exhibit
    • Information for Exhibitors
    • Sponsors & Exhibitors List
    • Digital Catalogue 2019
  • Sponsorship
  • Registration
  • Accommodations
    • Hotel Accommodations
    • Accommodation Reservation
  • Business Forum
    • Networking
  • Social
    • Satellite Events
    • Publications
    • Social Networks & PR Services
    • Media Partners
  • General
    • About Us
    • About Tel-Aviv
    • FAQ
    • Biomed 2018 by the Numbers
    • Gallery
    • Tours for Visitors
    • Privacy Policy
  • Contact

NeuroDerm Achieves Primary Endpoint in ND0612H Phase II Trial for Advanced Parkinson’s Disease; Seeks Broader EU Label Based on iNDiGO Trial Following EMA Meeting

  • admin
  • March 6, 2017
  • Blog

- Trial 006 demonstrated a statistically significant and clinically meaningful reduction in OFF-time and increase in proportion of patients “ON” by 8:00 am (primary and key secondary endpoints) - -…

Continue Reading

Gamida #Cell Announces First Patient #Transplanted in Phase 3 Registration Study of NiCord for #Blood #Cancers

  • admin
  • March 6, 2017
  • Blog

JERUSALEM, Feb. 28, 2017 /PRNewswire/ -- Gamida Cell, a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, announced today that the first patient…

Continue Reading

#Biomed2017 – XACT Robotics raises $5m

  • admin
  • March 5, 2017
  • Blog

10 Aug, 2015 15:07 Gali Weinreb The Israeli company will use the investment to fund US trials for its needle steering technology. XACT Robotics, an Israeli startup developing novel platform…

Continue Reading

Medisafe Takes In $14.5M to Help Patients Manage Medications

  • admin
  • March 5, 2017
  • Blog

 Jeff Engel Prescriptions can be complicated and confusing, especially for patients taking more than one set of pills. But when people don’t properly follow their prescription plans, it can lead…

Continue Reading

Pharma Two B raises $30M for Parkinson’s phase 3 from Biogen-backed fund, adds ex-Pfizer CEO to board

  • admin
  • February 28, 2017
  • Blog

by Nick Paul Taylor | Feb 27, 2017 7:34am Pharma Two B will run a phase 3 of its pramipexole-rasagiline fixed-dose combination P2B001. Pharma Two B has raised $30 million…

Continue Reading

7 disruptive innovations from medical device suppliers

  • admin
  • February 28, 2017
  • Blog

Medical device innovation doesn’t just come from small, single-product startups – contract manufacturers are increasingly a part of developing truly disruptive medtech.  Chris Newmarker, Managing Editor People sometimes make the mistake…

Continue Reading

Medtech Insight’s weekly podcast on Biomed Israel and Israeli medical devices & digital health companies

  • admin
  • February 27, 2017
  • Blog

Listen to Medtech Insight's podcast on selected Israeli medical device & digital health companies that was broadcast this week. On this week's Medtech Insight podcast: the response by a US…

Continue Reading

Genetically engineered T-cells treat leukemia in babies

  • admin
  • February 27, 2017
  • Blog

Genetically engineered T-cells treat leukemia in babies February 16, 2017 By Danielle Kirsh Researchers in London have successfully treated leukemia in two babies, in what they are touting as the…

Continue Reading

MindUP incubator takes in first startup

  • admin
  • February 27, 2017
  • Blog

Hemonitor measures blood flow in the main artery of intensive care patients. The MindUP technology incubator, a partnership between Pitango Venture Capital, the Rambam Health Care Campus, medical device company…

Continue Reading

Intensix Data Analytics Demo High Accuracy In ICU Sepsis Detection

  • admin
  • February 27, 2017
  • Blog

Catherine Longworth@MedtechCate [email protected] Executive Summary An analytics platform developed by Israeli big data company Intensix has shown high accuracy for detecting and predicting sepsis in critical care. The positive results…

Continue Reading
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22

Recent Posts

  • To save the most precious – Life! (Russian)
  • 30 Israeli companies bring medtech innovations to North of England
  • The biomed market is flourishing, so how can the generics companies stay out of the party?
  • ‘Greatest emerging market’? Cannabis-based drug R&D finally going mainstream
  • The bio-tech industry has been identified as an economic growth in Israel

Archives

  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • November 2018
  • October 2018
  • September 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • August 2016

Categories

  • Blog
  • News
  • PR

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Design and Develop: Navot Ram Web Solutions | All rights reserved to Kenes Exhibitions Inc. | SEO & Social Media, Ads by World Class Vision